Coya Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Coya Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2021 to 2023.
  • Coya Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $775K, a 195% increase year-over-year.
  • Coya Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $2.11M, a 199% increase year-over-year.
  • Coya Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $872K, a 321% increase from 2022.
  • Coya Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $207K, a 11.1% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $872K +$665K +321% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 $207K -$25.9K -11.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 $233K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.